Skip to main content

MoneyWorks4Me

Coral Laboratories submits copy of statement of deviation or variation

04 Oct 2016 Evaluate

Coral Laboratories has submitted a copy of the statement of deviation or variation in public issue, rights issue, preferential issue etc. for the quarter ended September 30, 2016 under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.10
Dr. Reddys Labs. 1369.45
Cipla 1409.30
Lupin 1994.65
Zydus Lifesciences 1206.05
View more..